Aduro Biotech Company Profile (NASDAQ:ADRO)

About Aduro Biotech

Aduro Biotech, Inc. is a clinical-stage immunotherapy company. The Company is focused on the discovery, development and commercialization of therapies that transform the treatment of various diseases. The Company has developed approximately three technology platforms, which include Live, Attenuated, Double-Deleted (LADD), Stimulator of Interferon Genes (STING) Pathway Activator and B-select monoclonal antibodies. Its LADD product candidates include CRS-207, ADU-623, ADU-741 and ADU-214. Its STING Activator product candidates include ADU-S100. Its LADD technology platform is engineered to express tumor-associated antigens to induce specific and targeted immune responses. Its STING Pathway Activator platform is designed to activate the intracellular STING receptor, resulting in a tumor-specific immune response. Its B-select monoclonal antibody platform includes various immune modulating assets in research and preclinical development.

Industry, Sector and Symbol:

• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Exchange: NASDAQ
• Symbol: ADRO
• CUSIP:

Key Metrics:

• Previous Close: $14.54
• 50 Day Moving Average: $14.73
• 200 Day Moving Average: $13.14
• 52-Week Range: $7.26 - $34.95
• Trailing P/E Ratio: N/A
• Foreward P/E Ratio: -8.17
• P/E Growth: 0.24
• Market Cap: $865.11M
• Outstanding Shares: 64,754,000
• Beta: 3.87

Profitability:

• Net Margins: -23.69%
• Return on Equity: -9.23%
• Return on Assets: -4.87%

Debt:

• Current Ratio: 10.22%
• Quick Ratio: 10.22%

Additional Links:

• Visit Aduro Biotech's Official Website
• View ADRO on Google Finance
• View ADRO on Yahoo Finance
• View ADRO's Company Profile on Reuters
• Search for Aduro Biotech Inc. on Google

Companies Related to Aduro Biotech:

• Theravance Biopharma (NASDAQ:TBPH)
• Select Medical Holdings Corp. (NYSE:SEM)
• Alder BioPharmaceuticals (NASDAQ:ALDR)
• USANA Health Sciences (NYSE:USNA)
• Amedisys (NASDAQ:AMED)
• NxStage Medical (NASDAQ:NXTM)
• Zeltiq Aesthetics (NASDAQ:ZLTQ)
• AMN Healthcare Services (NYSE:AHS)
• Halyard Health (NYSE:HYH)
• Halozyme Therapeutics (NASDAQ:HALO)

Earnings

Earnings History for Aduro Biotech (NASDAQ:ADRO)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call	Details
11/21/2016
8/3/2016		($0.18)	$0.03	$25.24 million	$39.00 million	View	N/A
5/2/2016	Q116	($0.25)	($0.45)			View	N/A
3/8/2016	Q415	($0.15)	$0.04		$34.38 million	View	N/A
11/24/2015	Q3	($0.08)	$0.01	$15.80 million	$19.15 million	View	N/A
8/10/2015	Q215	($0.01)	($0.50)	$1.00 million	$9.90 million	View	N/A
5/28/2015	Q115	($0.03)	($39.97)		$9.60 million	View	N/A

(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Aduro Biotech (NASDAQ:ADRO)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	8	($0.52)	($0.10)	($0.29)
Q2 2016	7	($0.46)	$0.11	($0.18)
Q3 2016	7	($0.52)	($0.20)	($0.43)
Q4 2016	7	($0.56)	($0.21)	($0.45)
Q1 2017	1	($0.50)	($0.50)	($0.50)
Q2 2017	1	($0.50)	($0.50)	($0.50)
Q3 2017	1	($0.51)	($0.51)	($0.51)
Q4 2017	1	($0.51)	($0.51)	($0.51)

(Data provided by Zacks Investment Research)

Dividends

Dividend History for Aduro Biotech (NASDAQ:ADRO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Aduro Biotech (NASDAQ:ADRO)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
9/19/2016	Jennifer Lew	Insider	Sell	6,360	$14.95	$95,082.00
9/1/2016	Thomas W Dubensky	Insider	Sell	25,000	$14.03	$350,750.00
8/11/2016	Thomas W Dubensky	Insider	Sell	25,000	$15.18	$379,500.00
7/5/2016	Thomas W Dubensky	Insider	Sell	25,000	$11.61	$290,250.00
5/16/2016	Thomas W. Dubensky	Insider	Sell	905	$8.20	$7,421.00
1/11/2016	Dirk G. Brockstedt	VP	Sell	22,000	$21.77	$478,940.00
1/8/2016	Gregory W. Schafer	COO	Sell	20,000	$23.58	$471,600.00
1/6/2016	Jennifer Lew	VP	Sell	5,242	$25.71	$134,771.82
1/5/2016	Stephen T. Isaacs	CEO	Sell	25,000	$26.31	$657,750.00
1/4/2016	Thomas W. Dubensky	insider	Sell	15,000	$26.37	$395,550.00
12/7/2015	Gregory W. Schafer	COO	Sell	25,000	$29.74	$743,500.00
12/3/2015	Jennifer Lew	VP	Sell	5,242	$29.85	$156,473.70
12/1/2015	Stephen T. Isaacs	CEO	Sell	25,000	$29.11	$727,750.00
12/1/2015	Thomas W. Dubensky	insider	Sell	30,000	$29.27	$878,100.00
11/18/2015	Jennifer Lew	VP	Sell	6,712	$28.52	$191,426.24
11/17/2015	Gregory W. Schafer	COO	Sell	26,470	$28.15	$745,130.50
11/17/2015	Thomas W. Dubensky	insider	Sell	31,470	$28.27	$889,656.90
11/16/2015	Stephen T. Isaacs	CEO	Sell	25,000	$27.54	$688,500.00
4/20/2015	Jennifer Lew	VP	Buy	2,000	$17.00	$34,000.00
4/20/2015	Venture (Vi) Inves Morningside	Major Shareholder	Buy	441,176	$17.00	$7,499,992.00
4/20/2015	William Mariner Greenman	Director	Buy	3,000	$17.00	$51,000.00

(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Aduro Biotech (NASDAQ:ADRO)

Date	Headline
	Aduro BioTech, Inc. breached its 50 day moving average in a Bearish Manner : ADRO-US : September 26, 2016 (NASDAQ:ADRO) www.capitalcube.com - September 26 at 3:17 PM
	Aduro Biotech's Stephen T. Isaacs Named 2016 Visionary Leader by Berkeley Chamber of Commerce - GlobeNewswire (press release) (NASDAQ:ADRO) www.globenewswire.com - September 26 at 8:41 AM
	Aduro Biotech’s Stephen T. Isaacs Named 2016 Visionary Leader by Berkeley Chamber of Commerce (NASDAQ:ADRO) www.publicnow.com - September 26 at 8:41 AM
	Shares Of Aduro BioTech Inc (NASDAQ:ADRO) Expected To Hit $22 - Investor Newswire (NASDAQ:ADRO) www.investornewswire.com - September 25 at 3:39 PM
	Coal India pushes into solar (NASDAQ:ADRO) www.publicnow.com - September 23 at 8:07 AM
	Indonesia can apply ‘clean’ coal technology to reduce emissions (NASDAQ:ADRO) www.publicnow.com - September 23 at 8:07 AM
	Coal Rises From Grave to Become One of Hottest Commodities (NASDAQ:ADRO) www.publicnow.com - September 23 at 8:07 AM
	China Seen Investing Too Much in Power Plants That Burn Coal (NASDAQ:ADRO) www.publicnow.com - September 23 at 8:07 AM
	Coal Prices Surge Higher, But Could Retreat Soon As Production Caps Are Lifted (NASDAQ:ADRO) www.publicnow.com - September 23 at 8:07 AM
	Coal’s cost advantage over LNG slipping, but not yet enough: Russell (NASDAQ:ADRO) www.publicnow.com - September 23 at 8:07 AM
	China Coal Control Jolts World Markets From Steel to Freight (NASDAQ:ADRO) www.publicnow.com - September 23 at 8:07 AM
	Aduro Biotech to Present at LEERINK Partners Roundtable Series - Yahoo Finance (NASDAQ:ADRO) finance.yahoo.com - September 22 at 3:18 PM
	Aduro Biotech to Present at LEERINK Partners Roundtable Series (NASDAQ:ADRO) www.publicnow.com - September 22 at 8:51 AM
	Aduro BioTech Inc (NASDAQ:ADRO) Receives Consensus Rating of “Buy” from Brokerages - DailyQuint (NASDAQ:ADRO) dailyquint.com - September 19 at 8:05 AM
	Expected For Aduro BioTech Inc (NASDAQ:ADRO) Sales Of $144.695 - Investor Newswire (NASDAQ:ADRO) www.investornewswire.com - September 15 at 3:18 PM
	ADURO BIOTECH, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (NASDAQ:ADRO) biz.yahoo.com - September 14 at 8:35 PM
	Aduro Biotech Incorporated (NASDAQ:ADRO) Shorted Shares Increased 4.37% After Market Selling - Frisco Fastball (NASDAQ:ADRO) friscofastball.com - September 14 at 3:18 PM
	Shares Going Lower in Trade: Aduro BioTech, Inc. (NASDAQ:ADRO) - Post News (NASDAQ:ADRO) www.kentuckypostnews.com - September 13 at 3:19 PM
	Aduro BioTech, Inc. – Value Analysis (NASDAQ:ADRO) : September 13, 2016 (NASDAQ:ADRO) www.capitalcube.com - September 13 at 3:19 PM
	Aduro BioTech, Inc. breached its 50 day moving average in a Bearish Manner : ADRO-US : September 12, 2016 (NASDAQ:ADRO) www.capitalcube.com - September 12 at 3:19 PM
	Placing Aduro BioTech Inc (NASDAQ:ADRO) Shares Under the Microscope - Post News (NASDAQ:ADRO) www.kentuckypostnews.com - September 9 at 8:05 AM
	China’s Inner Mongolia cuts coal output by 10 pct in Jan-July (NASDAQ:ADRO) www.publicnow.com - September 9 at 8:05 AM
	The Challenge of Cutting Coal Dependence (NASDAQ:ADRO) www.publicnow.com - September 9 at 8:05 AM
	Intraday Active Biotech Stocks News: Aduro BioTech, Inc. (NASDAQ:ADRO), ImmunoGen, Inc. (NASDAQ:IMGN) - The Voice Registrar (NASDAQ:ADRO) voiceregistrar.com - September 8 at 3:18 PM
	What are Brokerage Firms Saying About Aduro BioTech Inc (NASDAQ:ADRO)? - Frisco Fastball (NASDAQ:ADRO) friscofastball.com - September 7 at 8:27 PM
	Consensus Analyst Thoughts for: Procter & Gamble Company (NYSE:PG) , Aduro Biotech, Inc. (NASDAQ:ADRO) - Wall Street Times (press release) (NASDAQ:ADRO) www.wallstreetnews24.com - September 7 at 12:16 PM
	Attention Seekers of Biotechnology: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Aduro BioTech Inc (NASDAQ ... - Post Registrar (NASDAQ:ADRO) postregistrar.com - September 7 at 12:16 PM
	News review of 2 biotech stocks: Aduro BioTech, Inc. (NASDAQ:ADRO), CTI BioPharma Corp. (NASDAQ:CTIC) - The Voice Registrar (NASDAQ:ADRO) voiceregistrar.com - September 6 at 3:18 PM
	Aduro Biotech Appoints Oncology Expert and Industry Veteran Natalie Sacks, M.D. as Chief Medical Officer (NASDAQ:ADRO) finance.yahoo.com - September 6 at 8:04 AM
	A 360-degree sneak peek: Inside Berkeley biotech's new building - San Francisco Business Times (blog) (NASDAQ:ADRO) www.bizjournals.com - September 2 at 3:21 PM
	Aduro Biotech Announces New Corporate Offices and Laboratory Space - GlobeNewswire (press release) (NASDAQ:ADRO) globenewswire.com - September 2 at 5:28 AM
	A 360-degree sneak peek: Inside Berkeley biotech's new building (NASDAQ:ADRO) feeds.bizjournals.com - September 1 at 6:33 PM
	Aduro Biotech Announces New Corporate Offices and Laboratory Space - Yahoo Finance (NASDAQ:ADRO) finance.yahoo.com - September 1 at 3:18 PM
	Shares Slipping Lower Over the Past Month: Aduro BioTech, Inc. (NASDAQ:ADRO) - Post News (NASDAQ:ADRO) www.kentuckypostnews.com - September 1 at 3:18 PM
	Aduro Biotech Announces New Corporate Offices and Laboratory Space (NASDAQ:ADRO) www.publicnow.com - September 1 at 11:44 AM
	ETF’s with exposure to Aduro BioTech, Inc. : August 30, 2016 (NASDAQ:ADRO) www.capitalcube.com - August 30 at 12:18 PM
	Aduro BioTech, Inc. breached its 50 day moving average in a Bearish Manner : ADRO-US : August 29, 2016 (NASDAQ:ADRO) www.capitalcube.com - August 29 at 3:45 PM
	1H16 Financial Press Release (NASDAQ:ADRO) www.publicnow.com - August 29 at 3:45 PM
	Aduro BioTech Inc (NASDAQ:ADRO) Gets 1 Recommendations To ... - Investor Newswire (NASDAQ:ADRO) www.investornewswire.com - August 29 at 8:04 AM
	Best Biotech Stocks: This $15 Biotech Stock is About to Go Vertical (NASDAQ:ADRO) www.profitconfidential.com - August 26 at 11:25 AM
	PTBA Acquires Ignite Resources to Increase Efficiency (NASDAQ:ADRO) www.publicnow.com - August 26 at 11:25 AM
	Chinese July thermal coal imports jump 31% on year to 19-month high (NASDAQ:ADRO) www.publicnow.com - August 26 at 11:25 AM
	Vietnam’s July coal imports surge 141% on year to 1.31 million mt (NASDAQ:ADRO) www.publicnow.com - August 23 at 9:33 AM
	Metallurgical coal poised for biggest weekly price surge since 2011 Queensland floods (NASDAQ:ADRO) www.publicnow.com - August 23 at 9:33 AM
	Will Aduro BioTech Inc (NASDAQ:ADRO) Hit $22 Price Target? - Investor Newswire (NASDAQ:ADRO) www.investornewswire.com - August 22 at 8:06 AM
	How is the Crowd Rating Shares of Aduro BioTech Inc (NASDAQ:ADRO)? - Post News (NASDAQ:ADRO) www.kentuckypostnews.com - August 19 at 3:34 PM
	U.S. coal use may rise, but unlikely to unseat natgas as power king (NASDAQ:ADRO) www.publicnow.com - August 19 at 11:33 AM
	China’s Coal-Market Reforms Fuel Rebound in Prices (NASDAQ:ADRO) www.publicnow.com - August 19 at 11:33 AM
	Analysts See Sales Of $144.695 For Aduro BioTech Inc (NASDAQ:ADRO) - Investor Newswire (NASDAQ:ADRO) www.investornewswire.com - August 17 at 8:50 PM
	China steel, coal companies jump on debt-to-equity swap proposals (NASDAQ:ADRO) www.publicnow.com - August 16 at 11:55 AM

Social

Aduro Biotech (NASDAQ:ADRO) Chart for Monday, September, 26, 2016